Page last updated: 2024-10-28

ibudilast and Nervous System Disorders

ibudilast has been researched along with Nervous System Disorders in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Ibudilast (IBD) is a non‑selective (3, 4, 10, 11) phosphodiesterase (PDE) inhibitor, used mainly as a bronchodilator for the treatment of bronchial asthma."6.55Ibudilast: a non‑selective phosphodiesterase inhibitor in brain disorders. ( Kurkowska-Jastrzębska, I; Mirowska-Guzel, D; Schwenkgrub, J; Zaremba, M, 2017)
"Ibudilast (IBD) is a non‑selective (3, 4, 10, 11) phosphodiesterase (PDE) inhibitor, used mainly as a bronchodilator for the treatment of bronchial asthma."2.55Ibudilast: a non‑selective phosphodiesterase inhibitor in brain disorders. ( Kurkowska-Jastrzębska, I; Mirowska-Guzel, D; Schwenkgrub, J; Zaremba, M, 2017)
"Ibudilast is a relatively nonselective phosphodiesterase inhibitor which has been marketed for almost 20 years in Japan for treating asthma."2.45Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. ( Hutchinson, M; Johnson, K; Rolan, P, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwenkgrub, J1
Zaremba, M1
Mirowska-Guzel, D1
Kurkowska-Jastrzębska, I1
Rolan, P1
Hutchinson, M1
Johnson, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Regeneration in Cervical Degenerative Myelopathy - a Multi-centre, Double-blind, Randomised, Placebo Controlled Trial Assessing the Efficacy of Ibudilast as an Adjuvant Treatment to Decompressive Surgery for Degenerative Cervical Myelopathy[NCT04631471]Phase 3400 participants (Anticipated)Interventional2021-12-22Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for ibudilast and Nervous System Disorders

ArticleYear
Ibudilast: a non‑selective phosphodiesterase inhibitor in brain disorders.
    Postepy higieny i medycyny doswiadczalnej (Online), 2017, Mar-02, Volume: 71, Issue:0

    Topics: Animals; Brain Diseases; Brain Edema; Brain Infarction; Humans; Nervous System Diseases; Neurons; Ph

2017
Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease.
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:17

    Topics: Bronchodilator Agents; Humans; Nervous System Diseases; Pyridines; Respiratory Tract Diseases

2009